Remote electrical neuromodulation for acute migraine
Policy governs coverage determination for remote electrical neuromodulation (REN) devices (e.g., Nerivio) for acute treatment of migraine for Commercial Products under Blue Cross Blue Shield - Rhode Island.
Policy states REN for acute migraine is not covered / considered not medically necessary for Commercial Products.